News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
563,833 Results
Type
Article (45458)
Company Profile (110)
Press Release (518265)
Section
Business (159582)
Career Advice (1537)
Deals (29749)
Drug Delivery (101)
Drug Development (71203)
Employer Resources (118)
FDA (15038)
Job Trends (12534)
News (283719)
Policy (31232)
Tag
Academia (2480)
Alliances (48548)
Alzheimer's disease (1228)
Approvals (15011)
Artificial intelligence (186)
Bankruptcy (286)
Best Places to Work (10046)
Breast cancer (208)
Cancer (1581)
Cardiovascular disease (127)
Career advice (1297)
CAR-T (109)
Cell therapy (310)
Clinical research (57419)
Collaboration (643)
Compensation (329)
COVID-19 (2644)
C-suite (129)
Data (1480)
Diabetes (202)
Diagnostics (5114)
Earnings (56009)
Employer resources (110)
Events (74082)
Executive appointments (461)
FDA (15901)
Funding (527)
Gene therapy (220)
GLP-1 (684)
Government (4535)
Healthcare (16839)
Infectious disease (2759)
Interviews (253)
IPO (12958)
Job creations (2902)
Job search strategy (1132)
Layoffs (335)
Legal (7903)
Lung cancer (237)
Manufacturing (204)
Medical device (13438)
Medtech (13442)
Mergers & acquisitions (17140)
Metabolic disorders (556)
Neuroscience (1616)
NextGen: Class of 2025 (5684)
Non-profit (4022)
Northern California (1682)
Obesity (324)
Opinion (197)
Parkinson's disease (110)
Patents (147)
People (44820)
Phase I (17520)
Phase II (25193)
Phase III (19496)
Pipeline (617)
Postmarket research (2311)
Preclinical (7029)
Radiopharmaceuticals (238)
Rare diseases (271)
Real estate (4325)
Regulatory (20529)
Research institute (2245)
Resumes & cover letters (220)
Southern California (1401)
Startups (3012)
United States (14902)
Vaccines (667)
Weight loss (243)
Date
Today (8)
Last 7 days (498)
Last 30 days (2071)
Last 365 days (28999)
2025 (3722)
2024 (29657)
2023 (33820)
2022 (44123)
2021 (47701)
2020 (46646)
2019 (40359)
2018 (30884)
2017 (28015)
2016 (26987)
2015 (31071)
2014 (24065)
2013 (20091)
2012 (21541)
2011 (22164)
2010 (20464)
Location
Africa (724)
Arizona (143)
Asia (35487)
Australia (6100)
California (3757)
Canada (1420)
China (363)
Colorado (175)
Connecticut (203)
Europe (78753)
Florida (565)
Georgia (144)
Illinois (399)
Indiana (238)
Japan (114)
Maryland (692)
Massachusetts (2757)
Michigan (151)
Minnesota (266)
New Jersey (1135)
New York (1141)
North Carolina (672)
Northern California (1682)
Ohio (148)
Pennsylvania (900)
South America (996)
Southern California (1401)
Texas (561)
Utah (120)
Washington State (329)
563,833 Results for "auris medical ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ActivePure Medical’s Technology Dramatically Reduces Multidrug-Resistant Organisms in Hospitals Including Candida auris in New Studies
October 17, 2024
·
4 min read
Press Releases
Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs
November 26, 2024
·
4 min read
Deals
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
June 20, 2024
·
4 min read
Vaccines
CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64
The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.
October 24, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Hardy Diagnostics Releases Enrichment Broth for Candida auris Detection
July 16, 2024
·
4 min read
Drug Development
Melinta Therapeutics Announces Publication of the Outcomes by Candida Species from the ReSTORE Phase 3 trial and Recently Approved Rezafungin CLSI Breakpoints for Candida glabrata and Candida auris
Melinta Therapeutics Announces Publication of the Outcomes by Candida Species from the ReSTORE Phase 3 trial and Recently Approved Rezafungin CLSI Breakpoints for Candida glabrata and Candida auris.
May 23, 2024
·
4 min read
Press Releases
Medigene AG announces closing of its first SEPA tranche
February 4, 2025
·
2 min read
Drug Development
60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies of Tafenoquine Use in Candida spp, Including Candida auris
60 Degrees Pharmaceuticals, Inc. announced it will, through its majority-owned subsidiary 60P Australia Pty Ltd, sponsor a series of animal studies to investigate whether single dose parenteral administration of tafenoquine exhibits efficacy against Candida spp, including Candida auris.
February 20, 2024
·
9 min read
Press Releases
Bavarian Nordic Receives U.S. FDA Approval of Chikungunya Vaccine for Persons Aged 12 and Older
February 17, 2025
·
6 min read
Press Releases
Medigene AG Expands Patent Portfolio with Patent Grant for its JOVI Technology in the U.S.
February 19, 2025
·
2 min read
1 of 56,384
Next
